Omega-3 fatty acids and cardiovascular disease: Summary of the 2016 agency of healthcare research and quality evidence review

Nutrients

Volumn 9, Issue 8, 2017, Pages

  Balk, Ethan M ^a   Lichtenstein, Alice H ^b  

^a BROWN UNIVERSITY   (United States)

^b TUFTS UNIVERSITY   (United States)

Author keywords

Alpha linolenic acid; Blood pressure; Cardiovascular disease; Docosahexaenoic acid; Eicosapentaenoic acid; High density lipoprotein; Low density lipoprotein cholesterol; Marine oil; Meta analysis; Omega 3 fatty acids; Systematic review; Triglyceride

Indexed keywords

BIOLOGICAL MARKER; DOCOSAHEXAENOIC ACID; LOW DENSITY LIPOPROTEIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; OIL; OMEGA 3 FATTY ACID; PLACEBO; FISH OIL;

ADIPOSE TISSUE; ANGINA PECTORIS; ATRIAL FIBRILLATION; BLOOD PRESSURE; CARDIOMETABOLIC RISK; CARDIOVASCULAR DISEASE; CLINICAL OUTCOME; CONGESTIVE HEART FAILURE; DIETARY INTAKE; DOSE RESPONSE; DYSLIPIDEMIA; HEART ARRHYTHMIA; HUMAN; ISCHEMIC HEART DISEASE; PERCUTANEOUS CORONARY INTERVENTION; PLASMA; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; RISK FACTOR; SUDDEN CARDIAC DEATH; DIETARY SUPPLEMENT; GOVERNMENT; UNITED STATES;

CARDIOVASCULAR DISEASES; DIETARY SUPPLEMENTS; FATTY ACIDS, OMEGA-3; FISH OILS; HUMANS; UNITED STATES; UNITED STATES AGENCY FOR HEALTHCARE RESEARCH AND QUALITY;

EID: 85027358625     PISSN: None     EISSN: 20726643     Source Type: Journal    
DOI: 10.3390/nu9080865     Document Type: Review

References (19)

1. Scientific Report of the 2015 Dietary Guidelines Advisory Committee. 2015. Available online: http://health.gov/dietaryguidelines/2015-scientific-report/pdfs/scientific-report-of-the-2015-dietary-guidelines-advisory-committee.pdf (accessed on 7 August 2017).
2. Institute of Medicine. Dietary Reference Intakes. Energy, Carbohydrate, Fiber, Fat Fatty Acids, Cholesterol, Protein and Amino Acids; National Academy of Sciences: Washington, DC, USA, 2005.
3. Dietary Guidelines for Americans, 2010. Health. gov. Available online: https://health.gov/dietaryguidelines/dga2010/DietaryGuidelines2010.pdf (accessed on 7 August 2017).
4. Eckel, R.H.; Jakicic, J.M.; Ard, J.D.; Van Hubbard, S.; de Jesus, J.M.; Lee, I.-M.; Lichtenstein, A.H.; Loria, C.M.; Millen, B.E.; Miller, N.H.; et al. 2013 AHA/ACC Guideline on Lifestyle Management to Reduce Cardiovascular Risk: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. J. Am. Coll. Cardiol. 2014, 63, 3027–3028. [CrossRef] [PubMed]
5. Rehm, C.D.; Peñalvo, J.L.; Afshin, A.; Mozaffarian, D. Dietary Intake among US Adults, 1999–2012. JAMA 2016, 315, 2542–2553. [CrossRef] [PubMed]
6. Wang, C.; Chung, M.; Balk, E.; Kupelnick, B.; DeVine, D.; Lawrence, A.; Lichtenstein, A.; Lau, J. Effects of Omega-3 Fatty Acids on Cardiovascular Disease; Evidence Report/Technology Assessment No. 94 AHRQ Publication No. 04-E009-2; Agency for Healthcare Research and Quality: Rockville, MD, USA, 2004.
7. Balk, E.; Chung, M.; Lichtenstein, A.; Chew, P.; Kupelnick, B.; Lawrence, A.; DeVine, D.; Lau, J. Effects of Omega-3 Fatty Acids on Cardiovascular Risk Factors and Intermediate Markers of Cardiovascular Disease; Evidence Report/Technology Assessment No. 93 AHRQ Publication No. 04-E010-2; Agency for Healthcare Research and Quality: Rockville, MD, USA, 2004.
8. Wang, C.; Harris, W.S.; Chung, M.; Lichtenstein, A.H.; Balk, E.M.; Kupelnick, B.; Jordan, H.S.; Lau, J. n-3 Fatty acids from fish or fish-oil supplements, but not alpha-linolenic acid, benefit cardiovascular disease outcomes in primary- and secondary-prevention studies: A systematic review. Am. J. Clin. Nutr. 2006, 84, 5–17. [PubMed]
9. Balk, E.M.; Lichtenstein, A.H.; Chung, M.; Kupelnick, B.; Chew, P.; Lau, J. Effects of omega-3 fatty acids on serum markers of cardiovascular disease risk: A systematic review. Atherosclerosis 2006, 189, 19–30. [CrossRef] [PubMed]
10. Balk, E.M.; Lichtenstein, A.H.; Chung, M.; Kupelnick, B.; Chew, P.; Lau, J. Effects of omega-3 fatty acids on coronary restenosis, intima-media thickness, and exercise tolerance: A systematic review. Atherosclerosis 2006, 184, 237–246. [CrossRef] [PubMed]
11. Centers for Disease Control and Prevention. Cigarette Smoking Among Adults—United States, 2005–2015. Morb. Mortal. Wkly. Rep. 2016, 65, 1205–1211.
12. Flegal, K.M.; Carroll, M.D.; Kit, B.K.; Ogen, C.L. Prevalence of obesity and trends in the distribution of body mass index among US adults, 1999–2010. JAMA 2012, 307, 491–497. [CrossRef] [PubMed]
13. Balk, E.M.; Adam, G.P.; Langberg, V.; Halladay, C.; Chung, M.; Lin, L.; Robertson, S.; Yip, A.; Steele, D.; Smith, B.T.; Lau, J.; et al. Omega-3 Fatty Acids and Cardiovascular Disease: An Updated Systematic Review; Evidence Report/Technology Assessment No. 223 AHRQ Publication No. 16-E002-EF; Agency for Healthcare Research and Quality: Rockville, MD, USA, 2016.
14. Hodson, L.; Skeaff, C.M.; Fielding, B.A. Fatty acid composition of adipose tissue and blood in humans and its use as a biomarker of dietary intake. Prog. Lipid Res. 2008, 47, 348–380. [CrossRef] [PubMed]
15. Serra-Majem, L.; Nissensohn, M.; Øverby, N.C.; Fekete, K. Methods of assessment of n-3 long-chain polyunsaturated fatty acid status in humans: A systematic review. Am. J. Clin. Nutr. 2009, 89, 2070S–2084S.
16. Serra-Majem, L.; Nissensohn, M.; Øverby, N.C.; Fekete, K. Dietary methods and biomarkers of omega 3 fatty acids: A systematic review. Br. J. Nutr. 2012, 107 (Suppl. 2), S64–S76. [CrossRef] [PubMed]
17. Budoff, M. Triglycerides and Triglyceride-Rich Lipoproteins in the Causal Pathway of Cardiovascular Disease. Am. J. Cardiol. 2016, 118, 138–145. [CrossRef] [PubMed]
18. Nordestgaard, B.G. Triglyceride-Rich Lipoproteins and Atherosclerotic Cardiovascular Disease: New Insights from Epidemiology, Genetics, and Biology. Circ. Res. 2016, 118, 547–563. [CrossRef] [PubMed]
19. National Institute for Heath and Care Excellence. Cardiovascular Disease: Risk Assessment and Reduction, Including Lipid Modification, 2014. National Institute for Health and Care Excellence. Available online: https://www.nice.org.uk/guidance/CG181 (accessed on 27 July 2017).